Immunodeficiency secondary to anticytokine autoantibodies

Current Opinion in Allergy and Clinical Immunology

Volumn 10, Issue 6, 2010, Pages 534-541

  Browne, Sarah K ^a   Holland, Steven M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

anticytokine autoantibodies; immunodeficiency; opportunistic infection

Indexed keywords

AUTOANTIBODY; GAMMA INTERFERON ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 17A ANTIBODY; INTERLEUKIN 17F ANTIBODY; INTERLEUKIN 22 ANTIBODY; INTERLEUKIN 6 ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; AUTOIMMUNE POLYENDOCRINOPATHY; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CANDIDIASIS; DISSEMINATED NONTUBERCULOUS MYCOBACTERIUM INFECTION; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; LUNG ALVEOLUS PROTEINOSIS; MUCOCUTANEOUS CANDIDIASIS; MYCOBACTERIOSIS; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCAL SKIN INFECTION; THYMOMA;

ANTIBODIES, BLOCKING; AUTOANTIBODIES; CANDIDIASIS, CHRONIC MUCOCUTANEOUS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-6; INTERLEUKINS; MYCOBACTERIUM INFECTIONS, ATYPICAL; POLYENDOCRINOPATHIES, AUTOIMMUNE; PULMONARY ALVEOLAR PROTEINOSIS; STAPHYLOCOCCAL SKIN INFECTIONS; THYMOMA;

EID: 78449257063     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e3283402b41     Document Type: Review

References (58)

1. Uchida K, Beck DC, Yamamoto T, et al. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. N Engl J Med 2007; 356:567-579.
2. Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med 2003; 349:2527-2539.
3. Kisand K, Boe Wolff AS, Podkrajsek KT, et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med 2010; 207:299-308.
4. Puel A, Doffinger R, Natividad A, et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 2010; 207:291-297.
5. Riches PL, McRorie E, Fraser WD, et al. Osteoporosis associated with neutralizing autoantibodies against osteoprotegerin. N Engl J Med 2009; 361:1459-1465.
6. Hellmich B, Csernok E, Schatz H, et al. Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus. Arthritis Rheum 2002; 46:2384-2391.
7. Holland SM, DeLeo FR, Elloumi HZ, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007; 357:1608-1619.
8. Puel A, Picard C, Lorrot M, et al. Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6. J Immunol 2008; 180:647-654.
9. De Beaucoudrey L, Puel A, Filipe-Santos O, et al. Mutations in STAT3 and IL12RB1 impairthedevelopmentof human IL-17-producingTcells. J Exp Med 2008; 205:1543-1550.
10. Milner JD, Brenchley JM, Laurence A, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008; 452:773-776.
11. Ferwerda B, Ferwerda G, Plantinga TS, et al. Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 2009; 361:1760-1767.
12. Glocker EO, Hennigs A, Nabavi M, et al. A homozygous CARD9 mutation in a familywith susceptibilitytofungal infections. N Engl J Med 2009; 361:1727-1735.
13. Liang SC, Tan XY, Luxenberg DP, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of anti-microbial peptides. J Exp Med 2006; 203:2271-2279.
14. Aujla SJ, Kolls JK. IL-22:acritical mediatorin mucosal hostdefense. J Mol Med 2009; 87:451-454.
15. Wolk K, Kunz S, Witte E, et al. IL-22 increases the innate immunity oftissues. Immunity 2004; 21:241-254.
16. Dorman SE, Holland SM. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev 2000; 11:321-333.
17. Doffinger R, Helbert MR, Barcenas-Morales G, et al. Autoantibodies to interferon-gamma in a patientwith selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis 2004; 38: e10-e14.
18. Hoflich C, Sabat R, Rosseau S, et al. Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood 2004; 103:673-675.
19. Kampmann B, Hemingway C, Stephens A, et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest 2005; 115:2480-2488.
20. Patel SY, Ding L, Brown MR, et al. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol 2005; 175:4769-4776.
21. Tanaka Y, Hori T, Ito K, et al. Disseminated Mycobacterium avium complex infection in apatientwith autoantibodytointerferon-gamma. Intern Med 2007; 46:1005-1009.
22. Koya T, Tsubata C, Kagamu H, et al. Antiinterferon-gamma autoantibody in a patient with disseminated Mycobacterium avium complex. J Infect Chemother 2009; 15:118-122.
23. Chetchotisakd P, Kiertiburanakul S, Mootsikapun P, et al. Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. Clin Infect Dis 2007; 45:421-427.
24. Lai CC, Lee LN, Ding LW, et al. Emergence ofdisseminated infections dueto nontuberculous mycobacteria in non-HIV-infected patients, including immu-nocompetent and immunocompromised patients in a university hospital in Taiwan. J Infect 2006; 53:77-84.
25. Bonfield TL, Raychaudhuri B, Malur A, et al. PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimu-latingfactor. Am J Physiol Lung Cell Mol Physiol 2003; 285:L1132-L1136.
26. Chen BD, Mueller M, Chou TH. Role of granulocyte/macrophage colony-stimulatingfactor in the regulation ofmurinealveolarmacrophage proliferation and differentiation. J Immunol 1988; 141:139-144.
27. Shibata Y, Berclaz PY, Chroneos ZC, et al. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity2001; 15:557-567.
28. Carey B, Trapnell BC. The molecular basis of pulmonary alveolar proteinosis. Clin Immunol 2010; 135:223-235.
29. Ladeb S, Fleury-Feith J, Escudier E, et al. Secondary alveolar proteinosis in cancer patients. Support Care Cancer 1996; 4:420-426.
30. Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 1958; 258:1123-1142.
31. Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar protei-nosisasanautoimmunediseasewith neutralizingantibodyagainstgranulocyte/ macrophage colony-stimulating factor. J Exp Med 1999; 190:875-880. (Pubitemid 29451632)
32. Uchida K, Nakata K, Trapnell BC, et al. High- affinityautoantibodiesspecifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood 2004; 103:1089-1098.
33. Golde DW, Territo M, Finley TN, Cline MJ. Defective lung macrophages in pulmonary alveolar proteinosis. Ann Intern Med 1976; 85:304-309.
34. Gonzalez-Rothi RJ, Harris JO. Pulmonary alveolar proteinosis. Further evalua-tion of abnormal alveolar macrophages. Chest 1986; 90:656-661.
35. Kitamura T, Uchida K, Tanaka N, et al. Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000; 162:658-662.
36. Fried J, Hinthorn D, Ralstin J, et al. Cure of brain abscess caused by Nocardia asteroides resistant to multiple antibiotics. South Med J 1988; 81:412-413.
37. Walker DA, McMahon SM. Pulmonary alveolar proteinosis complicated by cerebralabscess:reportofacase. J Am Osteopath Assoc 1986; 86:447-450.
38. Oerlemans WG, Jansen EN, Prevo RL, Eijsvogel MM. Primary cerebellar nocardiosisand alveolarproteinosis. Acta Neurol Scand 1998; 97:138-141.
39. Clague HW, Harth M, Hellyer D, Morgan WK. Septic arthritisdueto Nocardia asteroides in association with pulmonary alveolar proteinosis. J Rheumatol 1982; 9:469-472.
40. Andersen BR, Ecklund RE, Kellow WF. Pulmonary alveolar proteinosis with systemic nocardiosis: a case report. JAMA 1960; 174:28-31.
41. Hartung M, Salfelder K. Pulmonary alveolar proteinosis and histoplasmosis: reportofthreecases. Virchows Arch A Pathol Anat Histol 1975;368:281-287.
42. Sunderland WA, Campbell RA, Edwards MJ. Pulmonary alveolar proteinosis and pulmonary cryptococcosis in an adolescent boy. J Pediatr 1972; 80:450-456.
43. Witty LA, Tapson VF, Piantadosi CA. Isolation of mycobacteria in patientswith pulmonary alveolar proteinosis. Medicine (Baltimore) 1994; 73:103-109.
44. Perheentupa J. APS-I/APECED: the clinical disease and therapy. Endocrinol Metab Clin North Am 2002; 31:295-320; vi.
45. Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in medullary thymicepithelial cellsmirrorsthe peripheralself. Nat Immunol 2001; 2:1032-1039.
46. Meager A, Visvalingam K, Peterson P, et al. Antiinterferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 2006; 3:e289.
47. Burbelo PD, Browne SK, Sampaio EP, et al. Anticytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia. Blood 2010. [Epub ahead of print]
48. Offerhaus GJ, Schipper ME, Lazenby AJ, et al. Graft-versus-host-like disease complicating thymoma: lack of AIRE expression as a cause of nonhereditary autoimmunity? Immunol Lett 2007; 114:31-37.
49. Scarpino S, Di Napoli A, Stoppacciaro A, et al. Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas. Clin Exp Immunol 2007; 149:504-512.
50. Kelleher P, Misbah SA. What is Good's syndrome? Immunological abnorm-alities in patients with thymoma. J Clin Pathol 2003; 56:12-16.
51. Castell JV, Gomez-Lechon MJ, David M, et al. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 1989; 242:237-239.
52. Watari K, Asano S, Shirafuji N, et al. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 1989; 73:117-122.
53. Eyles JL, Roberts AW, Metcalf D, Wicks IP. Granulocyte colony-stimulating factor and neutrophils: forgotten mediators of inflammatory disease. Nat Clin Pract Rheumatol 2006; 2:500-510.
54. Campion G, Maddison PJ, Goulding N, et al. The Felty syndrome: a case-matched studyof clinical manifestationsand outcome,serologicfeatures,and immunogenetic associations. Medicine (Baltimore) 1990; 69:69-80.
55. Ruderman M, Miller LM, Pinals RS. Clinical and serologic observations on 27 patients with Felty's syndrome. Arthritis Rheum 1968; 11:377-384.
56. Baerlecken N, Jacobs R, Stoll M, et al. Recurrent, multifocal Mycobacterium avium-intercellulare infection in a patient with interferon-gamma autoantibody. Clin Infect Dis 2009; 49:e76-e78.
57. Macdougall IC, Rossert J,Casadevall N, et al.A peptide-based erythropoietinreceptor agonist for pure red-cell aplasia. N Engl J Med 2009; 361:1848-1855.
58. Borie R, Debray MP, Laine C, et al. Rituximab therapy in autoimmune pulmonary alveolar proteinosis. Eur Respir J 2009; 33:1503-1506.